Paracetamol-associated acute liver failure in Australian and New Zealand children: High rate of medication errors

Archives of Disease in Childhood

Volumn 100, Issue 1, 2015, Pages 77-80

  Rajanayagam, J ^a   Bishop, J R ^a   Lewindon, P J ^b   Evans, Helen M ^a  

^a STARSHIP CHILDREN S HOSPITAL   (New Zealand)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; PARACETAMOL; ANALGESIC AGENT;

ACUTE LIVER FAILURE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUSTRALIA AND NEW ZEALAND; BILIRUBIN BLOOD LEVEL; CHILD; DRUG OVERDOSE; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; INFANT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICATION ERROR; OUTCOME ASSESSMENT; PRESCHOOL CHILD; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT DURATION; ADOLESCENT; AUSTRALIA; CHEMICALLY INDUCED; EPIDEMIOLOGY; NEW ZEALAND; STATISTICS AND NUMERICAL DATA;

ACETAMINOPHEN; ADOLESCENT; ANALGESICS, NON-NARCOTIC; AUSTRALIA; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; LIVER FAILURE, ACUTE; MALE; MEDICATION ERRORS; NEW ZEALAND; RETROSPECTIVE STUDIES;

EID: 84919346838     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/archdischild-2013-304902     Document Type: Article

References (15)

1. Daly FFS, Fountain JS, Murray L, et al. Guidelines for the management of paracetamol poisoning in Australia and New Zealand-explanation and elaboration. MJA 2008;188:296-301.
2. Kearns GL, Leeder JS, Wasserman GS. Acetaminophen overdose with therapeutic intent. J Pediatr 1998;132:5-8.
3. Heubi JE, Barbacci MB, Zimmerman HJ. Therapeutic misadventures with acetaminophen: hepatoxicity after multiple doses in children. J Pediatr 1998;132:22-7.
4. Rivera-Penera T, Gugig R, Davis J, et al. Outcome of acetaminophen overdose in pediatric patients and factors contributing to hepatoxicity. J Pediatr 1997;130:300-4.
5. NSW Therapeutic Advisory Group. Paracetamol Use: A position statement of the NSW Therapeutic Advisory Group Inc. 2008.
6. Squires RH Jr, Shneider BL, Bucuvalas J, et al. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr 2006;148:652-8.
7. Mahadevanm SK, McKiernan PJ, Davies P, et al. Paracetamol induced hepatotoxicity. Arch Dis Child 2006;91:598-603.
8. Miles FK, Kamath R, Dorney SF, et al. Accidental paracetamol overdosing and fulminant hepatic failure in children. Med J Aust 1999;171:472-5.
9. Ranganathan SS, Sathiadas MG, Sumanasena S, et al. Fulminant hepatic failure and paracetamol overuse with therapeutic intent in febrile children. Indian J Pediatr 2006;73:871-5.
10. Leonis M, Alonso E, Squires RH, et al. Chronic acetaminophen exposure in paediatric acute liver failure. J Pediatr 2013;131:740-6.
11. Cranswick N, Coghlan D. Paracetamol efficacy and safety in children: the first 40 years. Am J Ther 2000;7:135-41.
12. Warwich C. Paracetamol and fever management. JRSH 2008;128:320-3.
13. Squires RH, Dhawan A, Alonso E, et al. Intravenous N acetylcysteine in paediatric patients with nonacetaminophen acute liver failure: a placebo controlled clinical trial. J Hepatol 2013;57:1542-9.
14. Almuzaini T, Sammons H, Choonara I. Substandard and falsified medicines in the UK: a retrospective review of drug alerts (2001-2011). BMJ 2013;3:e002924.
15. Sammons H, Choonara I, Almuzaini T. Substandard and counterfeit medicines: a systematic review of the literature. BMJ 2013;3:e002923.